Management of patients with hormone receptor–positive breast cancer with visceral disease: challenges and treatment options

Endocrine therapy is an important treatment option for women with hormone receptor–positive (HR+) advanced breast cancer (ABC), yet many tumors are either intrinsically resistant or develop resistance to these therapies. Treatment of patients with ABC presenting with visceral metastases, which is as...

Descripción completa

Detalles Bibliográficos
Autor principal: Harb, Wael A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310719/
https://www.ncbi.nlm.nih.gov/pubmed/25653556
http://dx.doi.org/10.2147/CMAR.S72592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310719/
https://www.ncbi.nlm.nih.gov/pubmed/25653556
http://dx.doi.org/10.2147/CMAR.S72592

Ejemplares similares